Association between Voiding Dysfunction and Depression

Jung Woo Lee; Hong Sang Moon

doi:10.7599/hmr.2014.34.2.87

Journal List > Hanyang Med Rev > v.34(2) > 1044217

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Lee and Moon: Association between Voiding Dysfunction and Depression

Review Article

Hanyang Medical Reviews 2014; 34(2): 87-90.

Published online: 23 May 2014

DOI: https://doi.org/10.7599/hmr.2014.34.2.87

Association between Voiding Dysfunction and Depression

Jung Woo Lee, Hong Sang Moon

Department of Urology, Hanyang University College of Medicine, Seoul, Korea.

Correspondence to: Hong Sang Moon. Department of Urology, Hanyang University Guri Hospital, 153 Gyeongchun-ro, Guri 471-701, Korea. Tel: +82-31-560-2374, Fax: +82-31-560-2370, moonuro@hanyang.ac.kr

Received 20 February 2014 Revised 8 April 2014 Accepted 13 April 2014

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Depressive disorders have an overall incidence of 2-15%, and are among the most common mental illnesses. Depression is currently considered to be the fourth leading cause of premature death or disability, and it is expected to become the second leading cause of disease burden by 2020. It is closely related with the pathogenesis of many chronic diseases. Recently, some studies have shown the correlation of depressive disorders with lower urinary tract symptoms (LUTS) caused by benign prostatic hypertrophy, overactive bladder and other urological diseases. It is still unknown exactly what mechanism is the link between concomitant depression and LUTS, however differences in levels of antidiuretic hormone, inflammatory cytokines, phosphodiesterase isoenzyme and serotonin have been identified in patients suffering from depressive symptoms with LUTS. Numerous cross sectional studies and prospective cohort epidemiological investigations performed around the world have failed to demonstrate a clear causative mechanism for the relationship due to various limitations. Concomitant depression with LUTS creates a vicious cycle of suffering that significantly lowers the quality of life for patients. Further research is warranted to prevent progression of disease and improve the clinical outcome for patients with LUTS and associated depressive disorder.

Keywords: Depression, Lower Urinary Tract Symptoms, Socioeconomic Factors

References

1. Bertolote JM, Fleischmann A, De Leo D, Wasserman D. Psychiatric diagnoses and suicide: revisiting the evidence. Crisis. 2004; 25:147–155.

2. Ayuso-Mateos JL, Vazquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry. 2001; 179:308–316.

3. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62:593–602.

4. Oh DH, Kim SA, Lee HY, Seo JY, Choi BY, Nam JH. Prevalence and correlates of depressive symptoms in korean adults: results of a 2009 korean community health survey. J Korean Med Sci. 2013; 28:128–135.

5. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998; 4:1241–1243.

6. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007; 370:851–858.

7. Archer J, Hutchison I, Korszun A. Mood and malignancy: head and neck cancer and depression. J Oral Pathol Med. 2008; 37:255–270.

8. Sobel RM, Markov D. The impact of anxiety and mood disorders on physical disease: the worried not-so-well. Curr Psychiatry Rep. 2005; 7:206–212.

9. Lippi G, Montagnana M, Favaloro EJ, Franchini M. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost. 2009; 35:325–336.

10. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003; 54:269–282.

11. Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology. 2002; 59:245–250.

12. Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009; 103:Suppl 3. 4–11.

13. Asplund R, Johansson S, Henriksson S, Isacsson G. Nocturia, depression and antidepressant medication. BJU Int. 2005; 95:820–823.

14. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med. 1991; 229:131–134.

15. Asplund R, Henriksson S, Johansson S, Isacsson G. Nocturia and depression. BJU Int. 2004; 93:1253–1256.

16. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71:171–186.

17. Taraz M, Khatami MR, Dashti-Khavidaki S, Akhonzadeh S, Noorbala AA, Ghaeli P, et al. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. Int Immunopharmacol. 2013; 17:917–923.

18. Krogh J, Benros ME, Jorgensen MB, Vesterager L, Elfving B, Nordentoft M. The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav Immun. 2014; 35:70–76.

19. Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 2013; 112:432–441.

20. Kim SH, Jung KI, Koh JS, Min KO, Cho SY, Kim HW. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi? Urol Int. 2013; 90:144–149.

21. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65:732–741.

22. Wong ML, Whelan F, Deloukas P, Whittaker P, Delgado M, Cantor RM, et al. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc Natl Acad Sci U S A. 2006; 103:15124–15129.

23. Steers WD, Herschorn S, Kreder KJ, Moore K, Strohbehn K, Yalcin I, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 2007; 100:337–345.

24. Laumann EO, Kang JH, Glasser DB, Rosen RC, Carson CC. Lower urinary tract symptoms are associated with depressive symptoms in white, black and Hispanic men in the United States. J Urol. 2008; 180:233–240.

25. Klausner AP, Steers WD. Corticotropin releasing factor: a mediator of emotional influences on bladder function. J Urol. 2004; 172:2570–2573.

26. Wong SY, Hong A, Leung J, Kwok T, Leung PC, Woo J. Lower urinary tract symptoms and depressive symptoms in elderly men. J Affect Disord. 2006; 96:83–88.

27. Fitzgerald M, Link C, Litman H, Travison T, McKinlay J. Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol. 2007; 52:407–415.

28. Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Chirumamilla SL, Schoenberg ED, et al. Major depression drives severity of American Urological Association Symptom Index. Urology. 2010; 76:1317–1320.

29. Breyer BN, Kenfield SA, Blaschko SD, Erickson BA. The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005-2006 and 2007-2008 national health and nutrition examination survey. J Urol. 2014; 191:1333–1339.

30. Rom M, Schatzl G, Swietek N, Rucklinger E, Kratzik C. Lower urinary tract symptoms and depression. BJU Int. 2012; 110:E918–E921.

31. Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA. Nocturia associated with depressive symptoms. Urology. 2011; 77:183–186.

32. Yu HJ, Chen TH, Chie WC, Liu CY, Tung TH, Huang SW. Prevalence and associated factors of nocturia among adult residents of the Matsu area of Taiwan. J Formos Med Assoc. 2005; 104:444–447.

33. Van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int. 2002; 90:644–648.

34. Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999; 84:297–301.

35. Jennum P. Sleep and nocturia. BJU Int. 2002; 90:Suppl 3. 21–24.

36. Hakkinen JT, Shiri R, Koskimaki J, Tammela TL, Auvinen A, Hakama M. Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS). J Urol. 2008; 179:1897–1901.

37. Lee YI, Kim JW, Bae SR, Paick SH, Kim KW, Kim HG, et al. Effect of urgency symptoms on the risk of depression in community-dwelling elderly men. Korean J Urol. 2013; 54:762–766.

38. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008; 101:1388–1395.

TOOLS

Similar articles